Cargando…
Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583937/ https://www.ncbi.nlm.nih.gov/pubmed/37352527 http://dx.doi.org/10.1097/JS9.0000000000000550 |
| _version_ | 1785122653053386752 |
|---|---|
| author | Abdul Wahid, Maryam Hussain, Hassan ul Ghouri, Hafsa Khan, Tarneem Rehan, Syeda Tayyaba Mumtaz, Hassan |
| author_facet | Abdul Wahid, Maryam Hussain, Hassan ul Ghouri, Hafsa Khan, Tarneem Rehan, Syeda Tayyaba Mumtaz, Hassan |
| author_sort | Abdul Wahid, Maryam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10583937 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105839372023-10-19 Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? Abdul Wahid, Maryam Hussain, Hassan ul Ghouri, Hafsa Khan, Tarneem Rehan, Syeda Tayyaba Mumtaz, Hassan Int J Surg Correspondence Lippincott Williams & Wilkins 2023-06-22 /pmc/articles/PMC10583937/ /pubmed/37352527 http://dx.doi.org/10.1097/JS9.0000000000000550 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-sa/4.0/This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) , which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/ (https://creativecommons.org/licenses/by-sa/4.0/) |
| spellingShingle | Correspondence Abdul Wahid, Maryam Hussain, Hassan ul Ghouri, Hafsa Khan, Tarneem Rehan, Syeda Tayyaba Mumtaz, Hassan Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title | Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title_full | Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title_fullStr | Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title_full_unstemmed | Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title_short | Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| title_sort | programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583937/ https://www.ncbi.nlm.nih.gov/pubmed/37352527 http://dx.doi.org/10.1097/JS9.0000000000000550 |
| work_keys_str_mv | AT abdulwahidmaryam programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer AT hussainhassanul programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer AT ghourihafsa programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer AT khantarneem programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer AT rehansyedatayyaba programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer AT mumtazhassan programmeddeathligand1polyadenosinediphosphateribosepolymeraseandvascularendothelialgrowthfactorreceptorinhibitionapotentialcombinationregimenfortargetingtriplenegativebreastcancer |